Kalm Therapeutics, Inc. is a pre-clinical drug development company founded in 2024 and focused on pioneering a breakthrough treatment for eczema.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see KALM Therapeutics, Inc. →Already a subscriber? Sign in
Xcout Intel tracks KALM Therapeutics, Inc. continuously — this profile deepens as new filings, funding, people and hiring data arrive.